Habs, M.; Binder, K.; Krauss, S.; Müller, K.; Ernst, B.; Valentini, L.; Koller, M.
A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Herbal Medicinal Products Containing St. John’s Wort Extracts (SJW). Nutrients 2018, 10, 804.
https://doi.org/10.3390/nu10070804
AMA Style
Habs M, Binder K, Krauss S, Müller K, Ernst B, Valentini L, Koller M.
A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Herbal Medicinal Products Containing St. John’s Wort Extracts (SJW). Nutrients. 2018; 10(7):804.
https://doi.org/10.3390/nu10070804
Chicago/Turabian Style
Habs, Michael, Karin Binder, Stefan Krauss, Karolina Müller, Brigitte Ernst, Luzia Valentini, and Michael Koller.
2018. "A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Herbal Medicinal Products Containing St. John’s Wort Extracts (SJW)" Nutrients 10, no. 7: 804.
https://doi.org/10.3390/nu10070804
APA Style
Habs, M., Binder, K., Krauss, S., Müller, K., Ernst, B., Valentini, L., & Koller, M.
(2018). A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)—The Case of Herbal Medicinal Products Containing St. John’s Wort Extracts (SJW). Nutrients, 10(7), 804.
https://doi.org/10.3390/nu10070804